These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 15001208

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Systolic hypertension.
    Nash DT.
    Geriatrics; 2006 Dec; 61(12):22-8. PubMed ID: 17184139
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of spironolactone and losartan regarding long-term blood pressure and target organ damage.
    Baumann M, Hermans JJ, Janssen BJ, Peutz-Kootstra C, Witzke O, Heemann U, Smits JF, Boudier HA.
    J Hypertens; 2007 Dec; 25(12):2504-11. PubMed ID: 17984673
    [Abstract] [Full Text] [Related]

  • 32. [Blood pressure control in Europe is worse than in the USA].
    Minutolo R.
    G Ital Nefrol; 2007 Dec; 24(4):284. PubMed ID: 17659496
    [No Abstract] [Full Text] [Related]

  • 33. Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertension.
    Gaddam KK, Pratt-Ubunama MN, Calhoun DA.
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):353-9. PubMed ID: 16716096
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Antiproteinuric effects of mineralocorticoid receptor blockade in patients with chronic renal disease.
    Sato A, Hayashi K, Saruta T.
    Am J Hypertens; 2005 Jan; 18(1):44-9. PubMed ID: 15691616
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The effects of thiazide and thiazide-potassium sparing diuretics on fibrinolytic system parameters.
    Kaşifoğlu T, Yalçin AU.
    Anadolu Kardiyol Derg; 2006 Jun; 6(2):143-7. PubMed ID: 16766279
    [Abstract] [Full Text] [Related]

  • 39. Evolving understanding of the renin-angiotensin-aldosterone system: pathophysiology and targets for therapeutic intervention.
    Gradman AH.
    Am Heart J; 2009 Jun; 157(6 Suppl):S1-6. PubMed ID: 19450719
    [No Abstract] [Full Text] [Related]

  • 40. Endocrine arterial hypertension: therapeutic approach in clinical practice.
    Mazza A, Armigliato M, Zamboni S, Rempelou P, Rubello D, Pessina AC, Casiglia E.
    Minerva Endocrinol; 2008 Dec; 33(4):297-312. PubMed ID: 18923367
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.